Universe Pharmaceuticals INC (UPC)

CIK 0001809616 · Healthcare · Drug Manufacturers

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest FY-2025 —
FY-2024 —
FY-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover
—
Document and Entity Information
—
Audit Information
—
Statements
Consolidated Balance Sheets
—
Consolidated Balance Sheets (P)
—
Consolidated Statements of Income and Comprehensive Income
—
Consolidated Statements of Income and Comprehensive Income (P)
—
Consolidated Statements of Operations and Comprehensive Loss
—
Consolidated Statements of Changes In Shareholders Equity
—
Consolidated Statements of Cash Flows
—
Notes
Accounts Receivable, Net
—
Advance To Suppliers
—
Commitments and Contingencies
—
Concentrations
—
Cybersecurity Risk Management and Strategy Disclosure
—
Financial Information of The Parent Company
—
Insider Trading Policies and Procedures
—
Intangible Assets, Net
—
Inventories, Net
—
Inventory, Net
—
Long-term Bank Loans
—
Organization and Business Description
—
Other Receivable
—
Pay Vs Performance Disclosure
—
Prepayment For Acquisition
—
Prepayment For Cip Project
—
Prepayment For Purchase of A Property
—
Property and Equipment, Net
—
Property, Plant and Equipment, Net
—
Related Party Transactions
—
Shareholders' Equity
—
Short-term Bank Loans
—
Short-term Investments
—
Subsequent Events
—
Summary of Significant Accounting Policies
—
Taxes
—